Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
September 2005
Features
Commentary
Chronic Alert Fatigue Syndrome: An In-Your-Face Dilemma
With the proliferation of e-mail alerts, “chronic fatigue” takes on a whole new meaning.
Nancy L. Greengold, MD, MBA
Pharmaceutical Approval Update
Dr. Goldenberg discusses ramelteon (Rozerem™) for insomnia, a lidocaine–tetracaine patch (Synera™) for local dermal analgesia, and insulin detemir (Levemir®), a short-acting insulin analogue for type-1 and type-2 diabetes.
Marvin M. Goldenberg, PhD, RPh, MS
Meeting Highlights
65th Scientific Sessions of the American Diabetes Association
Some new therapies include tesaglitazar for insulin-resistant nondiabetic patients; vildagliptin, exenatide, metaglidasen, insulin glargine, pioglitazone, and rimonabant for problems associated with type-2 diabetes; inhaled insulin powder for type-1 diabetes; and pregabalin for reducing pain in diabetic peripheral neuropathy.
Lawrence M. Prescott, PhD, and Sharon L. Prescott
Continuing Education Credit
Skeletal Muscle Relaxants and Associated Medications for Nonspecific Acute Back Pain
The authors present an overview of some pharmacological and nonpharmacological modalities for treating the widespread public health problem of back pain, a major cause of disability in the U.S.
Roy R. Reeves, DO, PhD, Terrel L. Algood, RPh, and P. Melonee Wise, RPh
Departments
Editorial
Benefit Based Co-Pays: Fewer Tears
David Nash, MD, MBA, describes the concept of benefit-based co-payments, designed so that sick patients would pay less for medications than patients who use medications to prevent illness.
David Nash, MD, MBA
Medication Errors
Illusions and Medication Errors
Matthew Grissinger, RPh, FASCP, discusses ways to
reduce the potential for tricks of the mind, including illusions, faulty memory, and unconscious actions, all of which can affect the performance of health care professionals.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Making Drug Ads Add up: PhRMA Voluntary Guidelines Address Clarity and Accuracy, Not Spending
Stephen Barlas explains the recent voluntary guidelines
issued by PhRMA on direct-to-consumer drug advertising.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Acamprosate Calcium (Campral®): An Effective Treatment for Maintaining Abstinence in Alcohol-Dependent Patients in Combination with Psychosocial Support
Acamprosate calcium (Campral®) may help in
maintaining abstinence from alcohol.
Daniela Espino, PharmD, and Martin P. Cruz, PharmD, CGP
